Your browser is no longer supported. Please, upgrade your browser.
EYES Second Sight Medical Products, Inc. monthly Stock Chart
EYES [NASD]
Second Sight Medical Products, Inc.
Index- P/E- EPS (ttm)-2.34 Insider Own0.10% Shs Outstand15.61M Perf Week-0.56%
Market Cap22.00M Forward P/E- EPS next Y-1.40 Insider Trans-7.04% Shs Float13.18M Perf Month-41.15%
Income-33.60M PEG- EPS next Q-0.41 Inst Own3.80% Short Float5.88% Perf Quarter-81.95%
Sales3.40M P/S6.47 EPS this Y46.00% Inst Trans-1.21% Short Ratio2.08 Perf Half Y-86.51%
Book/sh0.47 P/B1.98 EPS next Y20.20% ROA-121.50% Target Price- Perf Year-83.63%
Cash/sh0.48 P/C1.95 EPS next 5Y- ROE-188.50% 52W Range0.71 - 8.96 Perf YTD-84.34%
Dividend- P/FCF- EPS past 5Y27.30% ROI-465.10% 52W High-89.62% Beta2.51
Dividend %- Quick Ratio1.70 Sales past 5Y-0.10% Gross Margin36.30% 52W Low30.96% ATR0.18
Employees112 Current Ratio1.90 Sales Q/Q-72.20% Oper. Margin- RSI (14)34.00 Volatility7.25% 13.79%
OptionableYes Debt/Eq0.00 EPS Q/Q47.90% Profit Margin- Rel Volume1.63 Prev Close0.95
ShortableYes LT Debt/Eq0.00 EarningsMar 25 AMC Payout- Avg Volume371.95K Price0.93
Recom1.50 SMA20-22.13% SMA50-42.14% SMA200-81.15% Volume607,911 Change-2.13%
Dec-13-19Initiated Dougherty & Company Buy $2
Jul-06-15Initiated H.C. Wainwright Buy $21
May-13-20 12:30PM  Second Sight Medical Products (EYES) May Report Negative Earnings: Know the Trend Ahead of Q1 Release Zacks -13.66%
May-05-20 01:08PM  Second Sight Medical Products Inc. Announces Closing of Public Offering of Common Stock Business Wire
Apr-30-20 08:43PM  Second Sight Medical Products Announces Pricing of Public Offering of Common Stock Business Wire -36.67%
Apr-28-20 08:00AM  Second Sight Medical Products Provides Business Update Business Wire +13.41%
Apr-01-20 09:04AM  Company News for Apr 1, 2020 Zacks
Mar-30-20 01:15PM  Second Sight Announces Employee Layoffs, Intent to Wind Down Operations and Appointment of Matthew Pfeffer as Acting CEO Business Wire -51.27%
Mar-27-20 03:23AM  Edited Transcript of EYES earnings conference call or presentation 19-Mar-20 8:30pm GMT Thomson Reuters StreetEvents -14.31%
Mar-19-20 05:15PM  Second Sight Medical Products (EYES) Reports Q4 Loss, Misses Revenue Estimates Zacks +9.99%
04:05PM  Second Sight Reports Fourth Quarter and Full Year 2019 Financial Results Business Wire
02:30PM  Second Sight Medical Products, Inc. to Host Earnings Call ACCESSWIRE
Mar-16-20 08:00AM  Second Sight to Discuss Fourth Quarter and Year-End 2019 Financial Results on March 19, 2020 Conference Call Business Wire -10.13%
Mar-12-20 04:15PM  Second Sight Announces Departure of Will McGuire, President and CEO, and Appointment of Gregg Williams as Acting CEO Business Wire -5.67%
Mar-04-20 12:30PM  Will Second Sight Medical Products (EYES) Report Negative Q4 Earnings? What You Should Know Zacks
Feb-28-20 08:07AM  Is Second Sight Medical Products, Inc. (NASDAQ:EYES) Excessively Paying Its CEO? Simply Wall St.
Jan-14-20 07:43AM  Can Second Sight Medical Products (NASDAQ:EYES) Afford To Invest In Growth? Simply Wall St.
Dec-04-19 11:05AM  Edited Transcript of EYES earnings conference call or presentation 14-Nov-19 9:30pm GMT Thomson Reuters StreetEvents
Nov-14-19 05:35PM  Second Sight Medical Products (EYES) Reports Q3 Loss, Lags Revenue Estimates Zacks -5.32%
04:05PM  Second Sight Reports Third Quarter 2019 Financial Results Business Wire
Nov-07-19 10:30AM  Will Second Sight Medical Products (EYES) Report Negative Earnings Next Week? What You Should Know Zacks
06:51AM  What Kind Of Investor Owns Most Of Second Sight Medical Products, Inc. (NASDAQ:EYES)? Simply Wall St.
Nov-05-19 04:30PM  Second Sight to Discuss Third Quarter 2019 Financial Results on November 14, 2019 Conference Call Business Wire +7.51%
Oct-30-19 10:33AM  Second Sight Medical Products (EYES) May Report Negative Earnings: Know the Trend Ahead of Q3 Release Zacks
Oct-02-19 08:30AM  Imagine Owning Second Sight Medical Products (NASDAQ:EYES) And Trying To Stomach The 77% Share Price Drop Simply Wall St.
Oct-01-19 08:00AM  Second Sight Announces $2.4 Million, Four-Year Grant from National Institutes of Health to Develop Spatial Localization and Mapping Technology Business Wire -6.78%
Sep-02-19 09:54AM  Edited Transcript of EYES earnings conference call or presentation 6-Aug-19 8:30pm GMT Thomson Reuters StreetEvents
Aug-28-19 08:00AM  Second Sight to Present at September Investor Conferences Business Wire
Aug-27-19 10:33AM  How Many Second Sight Medical Products, Inc. (NASDAQ:EYES) Shares Did Insiders Buy, In The Last Year? Simply Wall St.
Aug-06-19 07:05PM  Second Sight Medical Products (EYES) Reports Q2 Loss, Tops Revenue Estimates Zacks
04:05PM  Second Sight Reports Second Quarter 2019 Financial Results Business Wire
Jul-30-19 04:30PM  Second Sight to Discuss Second Quarter 2019 Financial Results on August 6, 2019 Conference Call Business Wire
10:38AM  Second Sight Medical Products (EYES) May Report Negative Earnings: Know the Trend Ahead of Q2 Release Zacks
Jul-11-19 10:53AM  How Much is Second Sight Medical Products, Inc.'s (NASDAQ:EYES) CEO Getting Paid? Simply Wall St.
Jun-25-19 04:05PM  Researchers Present Latest Positive Results of Second Sights Orion Visual Cortical Prosthesis Feasibility Study Business Wire
May-30-19 02:01PM  Edited Transcript of EYES earnings conference call or presentation 15-May-19 8:30pm GMT Thomson Reuters StreetEvents +7.75%
May-16-19 05:00PM  Second Sight to Present at 20th Annual B. Riley FBR Investor Conference Business Wire -8.42%
May-15-19 05:25PM  Second Sight Medical Products (EYES) Reports Q1 Loss, Misses Revenue Estimates Zacks -7.48%
04:15PM  Second Sight Medical Products: 1Q Earnings Snapshot Associated Press
04:05PM  Second Sight Reports First Quarter 2019 Financial Results Business Wire
04:01PM  Second Sight to Accelerate Development of Orion® Visual Cortical Prosthesis System Business Wire
May-08-19 08:00AM  Second Sight to Discuss First Quarter 2019 Financial Results on May 15, 2019 Conference Call Business Wire
May-02-19 10:32AM  Second Sight Medical Products (EYES) May Report Negative Earnings: Know the Trend Ahead of Q1 Release Zacks
Apr-17-19 09:13AM  Imagine Owning Second Sight Medical Products (NASDAQ:EYES) And Trying To Stomach The 80% Share Price Drop Simply Wall St. -5.66%
Apr-11-19 08:00AM  Second Sight Medical Products, Inc. Presents Positive Interim Results at the Fifth Annual BRAIN Initiative® Investigators Meeting Business Wire -9.21%
Apr-04-19 10:49AM  Zacks.com featured highlights include: VALE, Second Sight, Carbonite, Arconic and vTv Zacks
Apr-03-19 02:48PM  Edited Transcript of EYES earnings conference call or presentation 13-Mar-19 8:30pm GMT Thomson Reuters StreetEvents
07:57AM  Get Over Bargain Hunting: Tap 5 Stocks With Rising P/E Zacks
Mar-19-19 12:26PM  Zacks.com featured highlights include: Catabasis, Ligand, Key, Carbonite and Second Sight Zacks
Mar-18-19 09:02AM  Rising P/E an Overlooked Criterion: 5 Top Stocks Zacks
Mar-13-19 04:34PM  Second Sight Medical Products: 4Q Earnings Snapshot Associated Press
04:05PM  Second Sight Reports Fourth Quarter and Full Year 2018 Financial Results Business Wire
Mar-12-19 08:46AM  Have Insiders Been Buying Second Sight Medical Products, Inc. (NASDAQ:EYES) Shares This Year? Simply Wall St. +7.75%
Mar-06-19 08:00AM  Second Sight to Discuss Fourth Quarter and Year-End 2018 Financial Results on March 13, 2019 Conference Call Business Wire
Feb-21-19 06:06PM  Second Sight Medical Products, Inc. Announces Completion of Rights Offering Business Wire +5.33%
Jan-22-19 07:35AM  Recent Analysis Shows Abercrombie & Fitch, DaVita, W.W. Grainger, Ingredion, FirstEnergy, and Second Sight Medical Products Market Influences Renewed Outlook, Key Drivers of Growth GlobeNewswire
Jan-07-19 08:05AM  Second Sight Medical Products, Inc. Announces $40 Million Rights Offering of Units and Two Year Extension of Warrants (EYESW) Expiration Date GlobeNewswire
08:00AM  Second Sight Reports Fourth Quarter 2018 Business Update GlobeNewswire
Dec-20-18 08:00AM  Second Sight to Present at Digital Medicine and Medtech Showcase 2019 GlobeNewswire
Dec-14-18 08:00AM  Second Sight Completes $3 million Private Placement of Common Stock with Gregg Williams, Chairman of the Board of Directors GlobeNewswire +6.31%
Dec-04-18 06:18AM  Second Sight Medical Products Sees Hammer Chart Pattern: Time to Buy? Zacks -5.09%
Dec-03-18 08:17PM  Edited Transcript of EYES earnings conference call or presentation 7-Nov-18 9:30pm GMT Thomson Reuters StreetEvents
Nov-27-18 04:30PM  Second Sight to Present at the 11th Annual LD Micro Main Event Conference in Los Angeles on Wednesday, December 5th GlobeNewswire
Nov-12-18 08:15AM  Research Report Identifies Prudential Financial, Second Sight Medical Products, Acushnet, Repligen, Scorpio Tankers, and Aethlon Medical with Renewed Outlook Fundamental Analysis, Calculating Forward Movement GlobeNewswire -5.84%
Nov-07-18 07:10PM  Second Sight Medical Products (EYES) Reports Q3 Loss, Lags Revenue Estimates Zacks
06:06PM  Second Sight Medical Products: 3Q Earnings Snapshot Associated Press
04:01PM  Second Sight Reports Third Quarter 2018 Financial Results GlobeNewswire
Nov-06-18 04:01PM  Second Sight Announces Final 2019 Medicare Hospital Outpatient Payment Rate for the Argus II Retinal Prosthesis System GlobeNewswire
Oct-30-18 08:00AM  Second Sight to Discuss Third Quarter 2018 Financial Results on November 7, 2018 Conference Call Business Wire
Oct-22-18 09:00AM  Second Sight Completes $4 million Private Placement of Common Stock with Gregg Williams, Chairman of the Board of Directors Business Wire
Oct-18-18 08:30AM  New Research Coverage Highlights QuinStreet, Senseonics, Ring Energy, Blue Apron, Second Sight Medical Products, and Real Goods Solar Consolidated Revenues, Company Growth, and Expectations for 2018 GlobeNewswire
Sep-18-18 08:00AM  Second Sight Receives $1.6 Million Grant from National Institutes of Health to Support Orion Clinical Development Business Wire
Sep-04-18 08:00AM  Second Sight Appoints Pat Ryan Chief Operating Officer Business Wire
Aug-27-18 07:40AM  Analysis: Positioning to Benefit within C&J Energy Services, LivePerson, Kadmon, Cara Therapeutics, CorMedix, and Second Sight Medical Products Research Highlights Growth, Revenue, and Consolidated Results GlobeNewswire
Aug-22-18 08:00AM  Second Sight to Present at Investor Conferences in September Business Wire
Aug-16-18 08:26AM  Second Sight Medical Products (EYES): Moving Average Crossover Alert Zacks
08:00AM  Second Sight Completes $5.0 million Private Placement of Common Stock with Gregg Williams, Chairman of the Board of Directors Business Wire
03:35AM  Edited Transcript of EYES earnings conference call or presentation 7-Aug-18 8:30pm GMT Thomson Reuters StreetEvents
Aug-07-18 04:53PM  Second Sight Medical Products: 2Q Earnings Snapshot Associated Press
04:05PM  Second Sight Reports Second Quarter 2018 Financial Results Business Wire
02:30PM  Second Sight Medical Products, Inc. to Host Earnings Call ACCESSWIRE
Jul-31-18 08:00AM  Second Sight to Discuss Second Quarter 2018 Financial Results on August 7, 2018 Conference Call Business Wire
Jun-27-18 10:53AM  Second Sight Medical Products Incs (NASDAQ:EYES) Shift From Loss To Profit Simply Wall St.
Jun-21-18 08:25AM  Analysis: Positioning to Benefit within Second Sight Medical Products, ICF International, Morningstar, Spark Therapeutics, Natera, and Kadmon Research Highlights Growth, Revenue, and Consolidated Results GlobeNewswire
May-23-18 07:15AM  Complimentary Technical Snapshots on Prestige Brands and Three More Medical Equipment Stocks ACCESSWIRE
May-14-18 08:00AM  Second Sight Medical Products, Inc. to Present at the 19th Annual B. Riley FBR Investor Conference Business Wire
May-10-18 04:48PM  Second Sight Medical Products: 1Q Earnings Snapshot Associated Press -5.39%
04:01PM  Second Sight Reports First Quarter 2018 Financial Results Business Wire
May-07-18 08:00AM  Second Sight Completes $10 Million Private Placement of Common Stock with Gregg Williams, Chairman of the Board of Directors Business Wire -7.27%
May-03-18 05:00PM  Second Sight to Discuss First Quarter 2018 Financial Results on May 10, 2018 Conference Call Business Wire
May-01-18 08:10AM  Research Report Identifies Flexsteel Industries, Second Sight Medical Products, XG Technology, CRA International, Inc, Neos Therapeutics, and Tech Data with Renewed Outlook Fundamental Analysis, Calculating Forward Movement GlobeNewswire
Apr-09-18 04:30PM  Second Sight Announces Dr. Robert Greenbergs Resignation from Board of Directors and as an Officer of the Company Business Wire
Mar-22-18 08:00AM  Second Sight Appoints John T. Blake Chief Financial Officer Business Wire
Mar-19-18 07:30AM  Research Report Identifies Anthera Pharmaceuticals, Hancock Holding, MKS Instruments, Second Sight Medical Products, Eclipse Resources, and Aircastle with Renewed Outlook Fundamental Analysis, Calculating Forward Movement GlobeNewswire
Mar-16-18 08:00AM  Second Sight Appoints Gregg Williams as Chairman of the Board of Directors Business Wire
Mar-08-18 04:30PM  Second Sight Medical Products, Inc. to Present at the B. Riley & Co. China Healthcare Investment Partnering Symposium Business Wire -6.49%
Mar-07-18 05:47PM  Second Sight Medical Products posts 4Q loss Associated Press
04:05PM  Second Sight Reports Fourth Quarter and Full Year 2017 Financial Results Business Wire
12:30PM  Second Sight Medical Products, Inc. to Host Earnings Call ACCESSWIRE
Mar-06-18 08:00AM  Second Sight Announces Latest Expansion of Medicare Coverage for Argus II Retinal Prosthesis System Business Wire
Mar-05-18 08:00AM  Second Sight Medical Products, Inc. to Present at the Inaugural LD Micro Virtual Investor Conference on March 7, 2018 Business Wire +9.04%
Feb-28-18 08:00AM  Second Sight to Discuss Fourth Quarter and Year-End 2017 Financial Results on March 7, 2018 Conference Call Business Wire
Second Sight Medical Products, Inc. develops, manufactures, and markets implantable visual prosthetics that are intended to deliver artificial vision to blind individuals. It develops technologies to treat the population of sight-impaired individuals. The company offers the Orion Visual Cortical Prosthesis System, an implanted cortical stimulation device, which is intended to provide useful artificial vision to individuals who are blind due to various causes, including glaucoma, diabetic retinopathy, optic nerve injury or disease, and eye injury. It also offers Argus II Retinal Prosthesis System for treating retinitis pigmentosa. The company was founded in 1998 and is headquartered in Sylmar, California.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
McGuire Jonathan WillChief Executive OfficerFeb 20Sale5.441,7939,75423,826Feb 21 05:28 PM
McGuire Jonathan WillChief Executive OfficerAug 20Sale0.813,9023,151142,770Aug 20 08:36 PM
McGuire Jonathan WillChief Executive OfficerAug 19Option Exercise0.0011,8750146,672Aug 20 08:36 PM
Randolph Edward DavidVice President ManufacturingJun 04Sale0.7123,58616,64922Jun 04 07:26 PM